Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 7INDUSTRY 7NIH 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1

Interventions

Specimen Handling 12Vincristine 8Magnetic Resonance Spectroscopy 7Leucovorin 5Doxorubicin 5Cyclophosphamide 5X-Rays 4Radiotherapy 4Etoposide 4Cytarabine 4Cisplatin 4pegaspargase 3Radiotherapy, Conformal 3Radiation 3Prednisone 3Pemetrexed 3Lenalidomide 3High-Energy Shock Waves 3Gemcitabine 3Dexamethasone 3Dactinomycin 3Carboplatin 3Biopsy 3pembrolizumab 2merphos 2dexamethasone acetate 2dexamethasone 21-phosphate 2dehydroftorafur 2daratumumab 2calaspargase pegol 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Androgen Antagonists × 30 days × Clear all
NCT03419234 2026-06-03

Abiraterone Acetate and Antiandrogen Therapy With or Without Cabazitaxel and Prednisone in Treating Patients With Metastatic, Castration-Resistant Prostate Cancer Previously Treated With Docetaxel

Eastern Cooperative Oncology Group

Phase 2 Active not recruiting
223 enrolled 14 charts
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡